The Active B12 Test Market is expected to register a CAGR of 6.3% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Active B12 Test Market report covers analysis by Diagnosis (ELISA Assay, Enzyme Immunoassay, Others); Indication (Folate Deficiency Anemia, Pernicious Anemia, Macrocytic Anemia, Others); End User (Hospitals, Medical Laboratories, Clinical Research Organization, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Active B12 Test Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Active B12 Test Market Segmentation
Diagnosis- ELISA Assay
- Enzyme Immunoassay
- Folate Deficiency Anemia
- Pernicious Anemia
- Macrocytic Anemia
- Hospitals
- Medical Laboratories
- Clinical Research Organization
Strategic Insights
Active B12 Test Market Growth Drivers- Increased vitamin B12 deficiency awareness: With more people getting familiar with symptoms related to vitamin B12 deficiency, such as fatigue, cognitive dysfunction, and neurological problems, the requirements for accurate diagnostic tools, such as Active B12 testing, are on the rise. Due to the trend of health monitoring among people, test volumes are higher. This has, therefore, created a market where B12 testing is seen as necessary in the early diagnosis and management of potential deficiencies, especially in those who strictly follow dietary restrictions, such as vegans, vegetarians, and older adults who have higher risks of absorption issues.
- Increasing cases of Vitamin B12 Deficiency: The global prevalence of vitamin B12 deficiency is climbing due to various factors, including poor dietary intake, malabsorption conditions, and certain medical treatments. Populations most at risk, such as the elderly, pregnant women, and individuals with gastrointestinal disorders, often require specific attention to B12 levels. As the deficiency may cause severe health complications such as anemia, dementia, or neuropathy, the demand for diagnostic tests to detect low B12 levels is increasing to prevent and treat such health issues.
- Rise in Preventive Healthcare: This new direction in preventive healthcare means an emphasis on early diagnosis, monitoring, and prevention treatments. People increasingly require diagnostic tests for deficiencies and other conditions to ensure they are caught before full-blown medical problems appear. Active B12 testing well aligns with the preventive healthcare model because it helps intervene in time to avoid further complications arising from vitamin B12 deficiency. This trend toward prevention has heavily contributed to a surge in the demand for tests that measure bioactive nutrient levels, such as vitamin B12.
- Growing Use of Point-of-Care Testing: Point-of-care testing is becoming more popular because patients can get a rapid and accurate diagnosis at the time of consultation, without the hassle of transporting samples to laboratories or waiting for lab results. With POCT devices becoming user-friendly and less expensive, most healthcare facilities, especially clinics and outpatient centers, are shifting to point-of-care Active B12 tests. This convenience is driving demand as patients can get immediate results, which enhances the decision-making process for healthcare providers and allows for faster interventions.
- Combination of Active B12 Testing with Comprehensive Health Screenings: Active B12 tests are, therefore, getting included in normal health check-ups and wellness scans, where a person can undergo a variety of tests in the same sitting by monitoring their overall state of health. This is considered a trend wherein comprehensive and preventive care is finding more emphasis among people. By adding vitamin B12 testing to broader health screenings, patients and doctors can identify deficiencies earlier, leading to more effective management of health concerns, and encouraging patients to prioritize their long-term well-being.
- Growth of Digital Health Platforms: Digital health platforms and telemedicine services have made it easier for people to access healthcare services from the comfort of their homes. Many of these platforms now include the option to conduct Active B12 tests through partnerships with diagnostic companies, enabling patients to receive results online and consult with healthcare providers remotely. Another key trend in the market is the ability to track vitamin levels and manage deficiencies virtually, particularly because consumers are seeking more convenient at-home healthcare solutions.
- Development of Consumer-Oriented Testing Kits: The market for consumer-friendly testing kits of Active B12 is growing, especially as more home test kits are developed. They enable individuals to measure their levels of vitamin B12 privately and conveniently without needing to visit a healthcare provider or laboratory. Customers will be keen to use test kits that are easy to use and cost-effective, an aspect that would require companies to expand their portfolio and also enhance their market presence.
- Increased Demand in Nutritional Deficiencies and Holistic Health: As interest in holistic health and wellness increases, more interest is taken in nutritional deficiencies and their roles in overall health. Active B12 testing presents an answer to people who wish to optimize their health through the confirmation of adequate levels of the essential nutrients needed. Companies that place Active B12 testing in the context of a more comprehensive wellness or holistic health initiative will find favor in the emerging practice of being more proactive and knowledgeable about health.
- Corporations to Increase Preventive Health Programs: Corporations are investing more in preventive healthcare for their employees, as healthier employees mean lower healthcare costs and increased productivity. This trend includes offering health checkups that often include vitamin deficiency testing, such as Active B12 tests. Companies that provide these services to corporate clients can tap into a growing market for employee wellness programs, making it an excellent opportunity for diagnostic companies to expand their client base.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Active B12 Test Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Active B12 Test Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Active B12 Test Market are Increased vitamin B12 deficiency awareness, Increasing cases of Vitamin B12 Deficiency, and Rise in Preventive Healthcare
The key future trends of the market are Growing Use of Point-of-Care Testing, Combination of Active B12 Testing with Comprehensive Health Screenings, and Growth of Digital Health Platforms
The leading players operating in the Active B12 Test Market include Axis-Shield Diagnostics Ltd., Abbott, Siemens Healthcare Private Limited, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, LifeSpan BioSciences, Inc., Demeditec Diagnostics GmbH, New Stetic SA, Biohit Oyj.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Active B12 Test Market - By Diagnosis
1.3.2 Active B12 Test Market - By Indication
1.3.3 Active B12 Test Market - By End User
1.3.4 Active B12 Test Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ACTIVE B12 TEST MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ACTIVE B12 TEST MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ACTIVE B12 TEST MARKET - GLOBAL MARKET ANALYSIS
6.1. ACTIVE B12 TEST - GLOBAL MARKET OVERVIEW
6.2. ACTIVE B12 TEST - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ACTIVE B12 TEST MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS
7.1. OVERVIEW
7.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
7.3. ELISA ASSAY
7.3.1. Overview
7.3.2. ELISA Assay Market Forecast and Analysis
7.4. ENZYME IMMUNOASSAY
7.4.1. Overview
7.4.2. Enzyme Immunoassay Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. ACTIVE B12 TEST MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. FOLATE DEFICIENCY ANEMIA
8.3.1. Overview
8.3.2. Folate Deficiency Anemia Market Forecast and Analysis
8.4. PERNICIOUS ANEMIA
8.4.1. Overview
8.4.2. Pernicious Anemia Market Forecast and Analysis
8.5. MACROCYTIC ANEMIA
8.5.1. Overview
8.5.2. Macrocytic Anemia Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. ACTIVE B12 TEST MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. MEDICAL LABORATORIES
9.4.1. Overview
9.4.2. Medical Laboratories Market Forecast and Analysis
9.5. CLINICAL RESEARCH ORGANIZATION
9.5.1. Overview
9.5.2. Clinical Research Organization Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. ACTIVE B12 TEST MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Active B12 Test Market Overview
10.1.2 North America Active B12 Test Market Forecasts and Analysis
10.1.3 North America Active B12 Test Market Forecasts and Analysis - By Diagnosis
10.1.4 North America Active B12 Test Market Forecasts and Analysis - By Indication
10.1.5 North America Active B12 Test Market Forecasts and Analysis - By End User
10.1.6 North America Active B12 Test Market Forecasts and Analysis - By Countries
10.1.6.1 United States Active B12 Test Market
10.1.6.1.1 United States Active B12 Test Market by Diagnosis
10.1.6.1.2 United States Active B12 Test Market by Indication
10.1.6.1.3 United States Active B12 Test Market by End User
10.1.6.2 Canada Active B12 Test Market
10.1.6.2.1 Canada Active B12 Test Market by Diagnosis
10.1.6.2.2 Canada Active B12 Test Market by Indication
10.1.6.2.3 Canada Active B12 Test Market by End User
10.1.6.3 Mexico Active B12 Test Market
10.1.6.3.1 Mexico Active B12 Test Market by Diagnosis
10.1.6.3.2 Mexico Active B12 Test Market by Indication
10.1.6.3.3 Mexico Active B12 Test Market by End User
10.2. EUROPE
10.2.1 Europe Active B12 Test Market Overview
10.2.2 Europe Active B12 Test Market Forecasts and Analysis
10.2.3 Europe Active B12 Test Market Forecasts and Analysis - By Diagnosis
10.2.4 Europe Active B12 Test Market Forecasts and Analysis - By Indication
10.2.5 Europe Active B12 Test Market Forecasts and Analysis - By End User
10.2.6 Europe Active B12 Test Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Active B12 Test Market
10.2.6.1.1 Germany Active B12 Test Market by Diagnosis
10.2.6.1.2 Germany Active B12 Test Market by Indication
10.2.6.1.3 Germany Active B12 Test Market by End User
10.2.6.2 France Active B12 Test Market
10.2.6.2.1 France Active B12 Test Market by Diagnosis
10.2.6.2.2 France Active B12 Test Market by Indication
10.2.6.2.3 France Active B12 Test Market by End User
10.2.6.3 Italy Active B12 Test Market
10.2.6.3.1 Italy Active B12 Test Market by Diagnosis
10.2.6.3.2 Italy Active B12 Test Market by Indication
10.2.6.3.3 Italy Active B12 Test Market by End User
10.2.6.4 Spain Active B12 Test Market
10.2.6.4.1 Spain Active B12 Test Market by Diagnosis
10.2.6.4.2 Spain Active B12 Test Market by Indication
10.2.6.4.3 Spain Active B12 Test Market by End User
10.2.6.5 United Kingdom Active B12 Test Market
10.2.6.5.1 United Kingdom Active B12 Test Market by Diagnosis
10.2.6.5.2 United Kingdom Active B12 Test Market by Indication
10.2.6.5.3 United Kingdom Active B12 Test Market by End User
10.2.6.6 Rest of Europe Active B12 Test Market
10.2.6.6.1 Rest of Europe Active B12 Test Market by Diagnosis
10.2.6.6.2 Rest of Europe Active B12 Test Market by Indication
10.2.6.6.3 Rest of Europe Active B12 Test Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Active B12 Test Market Overview
10.3.2 Asia-Pacific Active B12 Test Market Forecasts and Analysis
10.3.3 Asia-Pacific Active B12 Test Market Forecasts and Analysis - By Diagnosis
10.3.4 Asia-Pacific Active B12 Test Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Active B12 Test Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Active B12 Test Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Active B12 Test Market
10.3.6.1.1 Australia Active B12 Test Market by Diagnosis
10.3.6.1.2 Australia Active B12 Test Market by Indication
10.3.6.1.3 Australia Active B12 Test Market by End User
10.3.6.2 China Active B12 Test Market
10.3.6.2.1 China Active B12 Test Market by Diagnosis
10.3.6.2.2 China Active B12 Test Market by Indication
10.3.6.2.3 China Active B12 Test Market by End User
10.3.6.3 India Active B12 Test Market
10.3.6.3.1 India Active B12 Test Market by Diagnosis
10.3.6.3.2 India Active B12 Test Market by Indication
10.3.6.3.3 India Active B12 Test Market by End User
10.3.6.4 Japan Active B12 Test Market
10.3.6.4.1 Japan Active B12 Test Market by Diagnosis
10.3.6.4.2 Japan Active B12 Test Market by Indication
10.3.6.4.3 Japan Active B12 Test Market by End User
10.3.6.5 South Korea Active B12 Test Market
10.3.6.5.1 South Korea Active B12 Test Market by Diagnosis
10.3.6.5.2 South Korea Active B12 Test Market by Indication
10.3.6.5.3 South Korea Active B12 Test Market by End User
10.3.6.6 Rest of Asia-Pacific Active B12 Test Market
10.3.6.6.1 Rest of Asia-Pacific Active B12 Test Market by Diagnosis
10.3.6.6.2 Rest of Asia-Pacific Active B12 Test Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Active B12 Test Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Active B12 Test Market Overview
10.4.2 Middle East and Africa Active B12 Test Market Forecasts and Analysis
10.4.3 Middle East and Africa Active B12 Test Market Forecasts and Analysis - By Diagnosis
10.4.4 Middle East and Africa Active B12 Test Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Active B12 Test Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Active B12 Test Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Active B12 Test Market
10.4.6.1.1 South Africa Active B12 Test Market by Diagnosis
10.4.6.1.2 South Africa Active B12 Test Market by Indication
10.4.6.1.3 South Africa Active B12 Test Market by End User
10.4.6.2 Saudi Arabia Active B12 Test Market
10.4.6.2.1 Saudi Arabia Active B12 Test Market by Diagnosis
10.4.6.2.2 Saudi Arabia Active B12 Test Market by Indication
10.4.6.2.3 Saudi Arabia Active B12 Test Market by End User
10.4.6.3 U.A.E Active B12 Test Market
10.4.6.3.1 U.A.E Active B12 Test Market by Diagnosis
10.4.6.3.2 U.A.E Active B12 Test Market by Indication
10.4.6.3.3 U.A.E Active B12 Test Market by End User
10.4.6.4 Rest of Middle East and Africa Active B12 Test Market
10.4.6.4.1 Rest of Middle East and Africa Active B12 Test Market by Diagnosis
10.4.6.4.2 Rest of Middle East and Africa Active B12 Test Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Active B12 Test Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Active B12 Test Market Overview
10.5.2 South and Central America Active B12 Test Market Forecasts and Analysis
10.5.3 South and Central America Active B12 Test Market Forecasts and Analysis - By Diagnosis
10.5.4 South and Central America Active B12 Test Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Active B12 Test Market Forecasts and Analysis - By End User
10.5.6 South and Central America Active B12 Test Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Active B12 Test Market
10.5.6.1.1 Brazil Active B12 Test Market by Diagnosis
10.5.6.1.2 Brazil Active B12 Test Market by Indication
10.5.6.1.3 Brazil Active B12 Test Market by End User
10.5.6.2 Argentina Active B12 Test Market
10.5.6.2.1 Argentina Active B12 Test Market by Diagnosis
10.5.6.2.2 Argentina Active B12 Test Market by Indication
10.5.6.2.3 Argentina Active B12 Test Market by End User
10.5.6.3 Rest of South and Central America Active B12 Test Market
10.5.6.3.1 Rest of South and Central America Active B12 Test Market by Diagnosis
10.5.6.3.2 Rest of South and Central America Active B12 Test Market by Indication
10.5.6.3.3 Rest of South and Central America Active B12 Test Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ACTIVE B12 TEST MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ACTIVE B12 TEST MARKET, KEY COMPANY PROFILES
13.1. AXIS-SHIELD DIAGNOSTICS LTD.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SIEMENS HEALTHCARE PRIVATE LIMITED
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DIASORIN S.P.A.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. F. HOFFMANN-LA ROCHE LTD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. LIFESPAN BIOSCIENCES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. DEMEDITEC DIAGNOSTICS GMBH
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NEW STETIC SA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIOHIT OYJ
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. EAGLEBIO
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. DOCTORCALL
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Axis-Shield Diagnostics Ltd.
2. Abbott
3. Siemens Healthcare Private Limited
4. DiaSorin S.p.A.
5. F. Hoffmann-La Roche Ltd
6. LifeSpan BioSciences, Inc.
7. Demeditec Diagnostics GmbH
8. New Stetic SA
9. Biohit Oyj
10. EagleBio
11. Doctorcall
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For